On May 25, 2026, TheMarker reported that the tender to sell the Wolt Market business had passed its initial stage, with contenders submitting preliminary bids. A group that included Good Pharm's founders (Ohad Sandler and Adam Fridler) together with Mor Investment House and Menora Mivtachim Pension submitted a bid; Migdal (which holds stakes in Israel Post and Pango) also expressed interest, alongside the Apax investment fund and other parties. By contrast, Victory, Leumi Partners, and Delek Israel — which had shown initial interest — did not advance to the next stage. According to TheMarker, Wolt Market is a loss-making business, and the tender also includes a growth-strategy proposal component, not price alone. On May 26, ice.co.il similarly reported Victory's withdrawal from the race, and Calcalist reported that Wolt Market expects an additional operating loss of about NIS 100 million over the next three years. The tender reached its decision stage by late July: on July 26, Ynet, Calcalist, and ice.co.il reported that four groups had submitted bids, with the highest bid at around NIS 300 million. According to Ynet, Paz and Good Pharm's founders are the two leading contenders — the only players with retail infrastructure capable of channeling significant activity into Wolt Market in the short term. A final decision on the buyer's identity is expected in the coming weeks, with industry observers estimating that price alone will not be decisive — Competition Authority approval will also be required.